Literature DB >> 2474287

Pontine myelinolysis and delayed encephalopathy following the rapid correction of acute hyponatremia.

J D Weissman1, B M Weissman.   

Abstract

We describe a case of pontine myelinolysis associated with hyponatremia and hyperammonemia resulting from bladder irrigation during a transurethral prostatic resection. Following the procedure the patient exhibited seizurelike activity. He underwent rapid correction of the hyponatremia, he initially recovered but developed encephalopathy 19 days later. Magnetic resonance images showed symmetrical lesions in the white matter of the cerebellar peduncles. A relatively small pontine lesion was also noted. The patient later recovered. This case demonstrates that myelinolysis associated with rapid correction of hyponatremia may be greater in the cerebellar peduncles than in the central pons.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474287     DOI: 10.1001/archneur.1989.00520440122030

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  4 in total

1.  Isotonic hyponatremia and cerebrospinal fluid sodium during and after transurethral resection of the prostate.

Authors:  Tomoko Baba; Yoshihiro Shibata; Kenichi Ogata; Ichirou Kukita; Tomoko Goto; Yasuyuki Hamada; Akihito Maehara; Yasuhiko Matsukado
Journal:  J Anesth       Date:  1995-06       Impact factor: 2.078

2.  Regressive dystonia and cerebellar ataxia: two unusual symptoms in central pontine myelinolysis.

Authors:  L Defebvre; P Rogelet; A Destée; A Verier
Journal:  J Neurol       Date:  1995-07       Impact factor: 4.849

Review 3.  Symptomatic hyponatraemia: can myelinolysis be prevented by treatment?

Authors:  C P Harris; J J Townsend; J R Baringer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154

4.  Reversible Cerebellar Ataxia Related to Extrapontine Myelinolysis without Hyponatremia after Cisplatin-Based Chemotherapy for Cholangiocarcinoma.

Authors:  Jae Heun Chung; Seung Kug Baik; Su-Hee Cho; Seong-Geun Kim
Journal:  Cancer Res Treat       Date:  2014-09-11       Impact factor: 4.679

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.